Related Experiment Video
Updated: Oct 31, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Prevalence of mild behavioral impairment in patients with mild cognitive impairment
Gilda Kianimehr1, Farzad Fatehi2, Maryam Noroozian3
1Department of Neuropsychiatry and Cognitive Neurology, Roozbeh Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran, Iran.
Abstract:
Over the past years, increasing attention has been paid to the frequency of neuropsychiatric symptoms (NPS) in dementia, also known as the behavioral and psychological symptoms of dementia. This study's main goal was to determine the prevalence of Mild Behavioral Impairment (MBI) and its subdomains in patients with Mild Cognitive Impairment (MCI) in Iran. Participants included 96 patients with MCI who attended the memory clinic between July and December 2020. Global cognitive function was evaluated using the Persian version of the Montreal Cognitive Assessment (MoCA). To assess MBI, the Persian version of the MBI checklist (MBI-C) was completed by the patient or a close caregiver. The mean age of patients was 71.4 ± 9.3 years, and 56 patients (58.3%) were female. Regarding the cutoff point of 6.5, 48 patients (50%) had MBI. In both groups of MBI and non-MBI, 28 (58%) were female. There was no significant difference in MBI subdomains scores and total MBI scores between the two genders. In addition, we found no significant difference in total MBI in patients with different risk factors. There was no significant difference in MoCA score between MBI and non-MBI patients (24.1 ± 3.9 versus 23.7 ± 4.0) (p = 0.59). NPS are highly prevalent in MCI patients, with the most common ones being impulse dyscontrol, emotional dysregulation, and decreased motivation. Psychotic symptoms and social inappropriateness are rare. New-onset psychiatric symptoms and behavioral changes in older adults, even in a mild form (MBI), should increase the suspicion of subsequent cognitive impairment.
Insights
Mild Behavioral Impairment (MBI) affects half of patients with Mild Cognitive Impairment (MCI). Common symptoms include impulse control issues, emotional dysregulation, and low motivation, signaling potential cognitive decline.
Area of Science:
- Neuroscience
- Geriatrics
- Psychiatry
Background:
- Neuropsychiatric symptoms (NPS) are increasingly recognized in dementia.
- Mild Behavioral Impairment (MBI) and its subdomains require further investigation in Mild Cognitive Impairment (MCI).
Purpose of the Study:
- To determine the prevalence of MBI and its subdomains in Iranian patients with MCI.
- To explore the relationship between MBI, gender, and cognitive function in MCI patients.
Main Methods:
- A cross-sectional study involving 96 MCI patients at a memory clinic.
- Cognitive function assessed using the Persian Montreal Cognitive Assessment (MoCA).
- MBI assessed via the Persian MBI Checklist (MBI-C) completed by patients or caregivers.
Main Results:
- 50% of MCI patients (48/96) met the criteria for MBI.
- No significant differences in MBI scores were found between genders or across different risk factors.
- No significant difference in MoCA scores between MBI and non-MBI groups (p=0.59).
- Most common NPS in MCI patients were impulse dyscontrol, emotional dysregulation, and decreased motivation.
Conclusions:
- NPS, particularly MBI, are highly prevalent in MCI patients in Iran.
- New-onset behavioral changes in older adults may indicate underlying cognitive impairment.
- MBI symptoms like impulse dyscontrol, emotional dysregulation, and apathy are common in MCI.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Related Concept Videos
Intellectual Disability
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists